| 000 | 01769 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515034824.0 | ||
| 264 | 0 | _c20060913 | |
| 008 | 200609s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm0512591 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPalmer, Brian D | |
| 245 | 0 | 0 |
_a4-Phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione inhibitors of the checkpoint kinase Wee1. Structure-activity relationships for chromophore modification and phenyl ring substitution. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cAug 2006 |
||
| 300 |
_a4896-911 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aBenzene Derivatives _xchemical synthesis |
| 650 | 0 | 4 |
_aCarbazoles _xchemical synthesis |
| 650 | 0 | 4 |
_aCell Cycle Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aCheckpoint Kinase 1 |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 |
_aNuclear Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aProtein Kinases _xchemistry |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPyrroles _xchemical synthesis |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aThompson, Andrew M | |
| 700 | 1 | _aBooth, R John | |
| 700 | 1 | _aDobrusin, Ellen M | |
| 700 | 1 | _aKraker, Alan J | |
| 700 | 1 | _aLee, Ho H | |
| 700 | 1 | _aLunney, Elizabeth A | |
| 700 | 1 | _aMitchell, Lorna H | |
| 700 | 1 | _aOrtwine, Daniel F | |
| 700 | 1 | _aSmaill, Jeff B | |
| 700 | 1 | _aSwan, Leesa M | |
| 700 | 1 | _aDenny, William A | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 49 _gno. 16 _gp. 4896-911 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm0512591 _zAvailable from publisher's website |
| 999 |
_c16472874 _d16472874 |
||